History Taking · Intermediate · O&G

Menopausal Symptoms and Hormone Replacement Therapy

Practise this PLAB 2 history taking station on Menopause. 8-minute voice AI simulation with feedback on all 3 marking domains.

Clinical scenario

You are an FY2 doctor in a GP practice. Mrs Rose Lambert, a 53-year-old woman, has come to see you about menopausal symptoms. She is experiencing hot flushes, night sweats, mood changes, and sleep disturbance for the past two years. Her last menstrual period was eighteen months ago. Please take a focused history and discuss management options including HRT, risks and benefits, lifestyle measures, and when to consider specialist referral.

Background notes: PMH: Hysterectomy age 41 (fibroids), fit and well otherwise

What this station tests

  • Oestrogen-only HRT after hysterectomy: no progesterone needed, lower breast cancer risk
  • Transdermal preferred over oral if VTE risk factors: avoids first-pass hepatic effect
  • Breast cancer risk distinction: oestrogen-only has little/no increased risk versus combined
  • Non-hormonal alternatives: CBT, SSRIs/SNRIs, clonidine for women who decline HRT
  • Starting within 10 years of menopause: cardiovascular benefit window

How to use your 8 minutes

  • 0-1 min — Introduction: Introduce yourself, confirm identity, open question. 'What's brought you in today?'
  • 1-4 min — Systematic History: Presenting complaint detail (SOCRATES for pain, timeline, severity). Systems review. PMH, medications, allergies.
  • 4-6 min — Context and ICE: Social history (smoking, alcohol, occupation, living situation). Family history. Ideas, Concerns, Expectations.
  • 6-7 min — Summary and Plan: Summarise findings back to patient. Share differential/working diagnosis. Outline investigation and management plan.
  • 7-8 min — Closing: Safety netting with specific red flags. Arrange follow-up. Check for questions.

Consultation approach

The opening

HRT counselling requires balanced risk-benefit discussion addressing the patient's specific concerns. Mrs Lambert is 53, had a hysterectomy at 41 for fibroids, and has been experiencing severe vasomotor symptoms. She wants HRT but fears breast cancer. Open with: 'Mrs Lambert, your symptoms sound like they are significantly affecting your quality of life. Tell me your main concern about HRT.'

Core approach

Her specific concern is breast cancer risk. Address this directly with evidence. 'The breast cancer risk with HRT depends on the type and duration. Because you have had a hysterectomy, you only need oestrogen-only HRT (no progesterone component). Oestrogen-only HRT has little or no increased breast cancer risk.' This is a critical distinction: combined HRT (oestrogen plus progesterone) carries a small increased breast cancer risk; oestrogen-only does not.

Benefits of HRT for her: vasomotor symptom relief (most effective treatment), bone protection (she has no uterus so no endometrial risk), improved sleep, improved mood, reduced cardiovascular risk if started within 10 years of menopause. Risks: VTE (small increased risk with oral, not with transdermal), stroke (small increased risk).

She had a hysterectomy, so she does not need the progesterone component (progesterone is only needed to protect the endometrium). This simplifies her regimen and reduces risk.

Closing and safety netting

If she chooses HRT: oestrogen-only (oral or transdermal patch/gel). Transdermal is preferred if she has VTE risk factors or is overweight (avoids first-pass hepatic effect, lower VTE risk). Start at lowest effective dose. Review at 3 months to assess response and side effects. Annual review thereafter.

Non-hormonal alternatives if she declines: CBT for vasomotor symptoms (NICE-recommended), SSRIs/SNRIs (venlafaxine, fluoxetine), clonidine. Lifestyle: regular exercise, cooling strategies, weight management.

Reassure: 'For you specifically, the benefits of HRT clearly outweigh the risks. Your symptoms are severe and HRT is the most effective treatment.' Safety net: 'If you develop leg swelling, chest pain, or unusual bleeding, come back.' Follow-up in 3 months.

How examiners mark this station

Examiners will focus on the thoroughness and structure of your history taking for menopause. Domain 1 (Data Gathering) carries the most weight: expect marks for systematic coverage of presenting complaint, red flags, PMH, medications, social and family history. Domain 2 (Clinical Management) requires a clear differential, appropriate investigations, and a safe management plan with safety netting. Domain 3 (Interpersonal Skills) is assessed throughout: genuine exploration of ICE, active listening, empathic responses, and clear communication without jargon.

Domain 1 (Supporting)

Scores well: Symptom severity assessed. Hysterectomy history noted (affects HRT type). VTE risk factors checked. Breast cancer risk factors assessed.

Costs marks: Not noting hysterectomy. Not checking VTE risk.

Domain 2 (Primary focus)

Scores well: Oestrogen-only prescribed (not combined). Transdermal option discussed. Non-hormonal alternatives offered. Review at 3 months. Breast cancer risk addressed accurately.

Costs marks: Combined HRT after hysterectomy. Overstating breast cancer risk. No alternatives.

Domain 3 (Primary focus)

Scores well: Addressing breast cancer fear directly with evidence. Shared decision-making. Acknowledging symptom impact on quality of life.

Costs marks: Dismissing her concern. Being directive. Not providing evidence.

Common examiner feedback (and how to fix it)

Did not gather sufficient information to make an adequate assessment of the patient's condition

Fix: Use a consistent framework for every history. After covering the presenting complaint, systematically move through PMH, drug history, social history, family history, and ICE. Keep a mental checklist.

Did not identify the patient's problems and/or did not develop a management plan adequately

Fix: Reserve the final 2 minutes to summarise your findings, share your working diagnosis with the patient, and outline your investigation and management plan including safety netting.

Common mistakes in this station

  1. Prescribing combined HRT after hysterectomy: progesterone is only needed if the uterus is present
  2. Overstating breast cancer risk for oestrogen-only HRT: the evidence shows little or no increase
  3. Not offering non-hormonal alternatives: some women cannot or will not take HRT and need options

Resitting PLAB 2?

If you have previously struggled with history taking stations, focus on building a consistent systematic framework that you apply to every case. Practise structuring your history into clear phases (presenting complaint, systems review, PMH, social, ICE) so that even under pressure, you cover all domains. Many resitters lose marks not on knowledge but on organisation and time management.

Example opening

Good morning/afternoon, my name is Dr [Name], I'm one of the doctors here today. Could I confirm your name and date of birth please? Thank you. So, what's brought you in to see me today?

Frequently asked questions

What is the best way to take a menopause history in PLAB 2?

HRT counselling requires balanced risk-benefit discussion addressing the patient's specific concerns. Mrs Lambert is 53, had a hysterectomy at 41 for fibroids, and has been experiencing severe vasomotor symptoms. She wants HRT but fears breast cancer.

Where are marks won and lost in this menopause station?

Examiners reward: Symptom severity assessed. Hysterectomy history noted (affects HRT type). VTE risk factors checked. Breast cancer risk factors assessed. Candidates are penalised for: Not noting hysterectomy. Not checking VTE risk.

Where do candidates most often go wrong in this station?

Prescribing combined HRT after hysterectomy: progesterone is only needed if the uterus is present. Another frequent error: Overstating breast cancer risk for oestrogen-only HRT: the evidence shows little or no increase.

Can I do well in this station without real-world experience of menopause?

This station rewards process over personal experience. The skill being assessed: Transdermal preferred over oral if VTE risk factors: avoids first-pass hepatic effect. Work through the consultation approach above, then rehearse it aloud under the 8-minute time pressure so the structure holds up in the exam.

Related cases